Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bluejay Diagnostics Inc

4.40
+0.32908.08%
Pre-market: 4.22-0.1800-4.09%07:03 EDT
Volume:102.04K
Turnover:456.35K
Market Cap:2.37M
PE:-0.03
High:4.80
Open:4.32
Low:4.20
Close:4.07
Loading ...

Company Profile

Company Name:
Bluejay Diagnostics Inc
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
10
Office Location:
360 Massachusetts Avenue,Suite 203,Acton,Massachusetts,United States
Zip Code:
01720
Fax:
- -
Introduction:
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Directors

Name
Position
Douglas C. Wurth
Director,Chairman of the Board
Neil Dey
President, Chief Executive Officer and Director
Donald R. Chase
Director
Fred S. Zeidman
Director
Gary Gemignani
Director
Svetlana Dey
Director

Shareholders

Name
Position
Neil Dey
President, Chief Executive Officer and Director
Kenneth Fisher
Chief Financial Officer
Jason Cook
Chief Technology Officer